Ubiquitin-like domains (Ubls) are now recognized as common elements adjacent to viral 26 and cellular proteases; however, their function is unclear. Structural studies of the papain-like 27 protease (PLP) domains of coronaviruses (CoVs) revealed an adjacent Ubl domain in Severe 28 Acute Respiratory Syndrome CoV, Middle East Respiratory Syndrome CoV, and the murine 29 CoV, mouse hepatitis virus (MHV). Here we tested the effect of altering the Ubl adjacent to 30 PLP2 of MHV on enzyme activity, viral replication and pathogenesis. Using deletion and 31 substitution approaches, we identified sites within the Ubl domain, residues 785-787 of 32 nonstructural protein 3, which negatively affect protease activity, and valine residues 785 and 33 787, which negatively affect deubiquitinating activity. Using reverse genetics, we engineered 34 Ubl-mutant viruses and found that AM2 (V787S) and AM3 (V785S) viruses replicate efficiently 35 at 37°C, but generate smaller plaques than WT virus, and AM2 is defective for replication at 36 higher temperatures. To evaluate the effect of the mutation on protease activity, we purified WT 37 and Ubl-mutant PLP2 and found that the proteases exhibit similar specific activities at 25°C.
Introduction
GloSensor (Promega) reagent diluted 1:50 in DMEM (10% FBS) was added. The luminescence 160 was measured using a luminometer (Veritas) every hour for 5 hours.
161
Generating Ubl-2 mutant viruses. To introduce mutations into MHV A59, we used a 162 previously described method (40) . Briefly, plasmid encoding the MHV B subclone was 163 mutagenized using primers described in table 1. Plasmids encoding the complete virus genome 164 were digested with restriction enzymes, gel purified, and ligated using T4 ligase at 16°C 165 overnight. The ligation reaction was isopropanol precipitated and in vitro RNA transcription was 166 performed using a mMESSAGE mMACHINE Kit (Ambion) according to the following 167 protocol: 40.5°C for 25 min, 37.5°C for 50 min, 40.5°C for 25 min. RNA was electroporated into 168 BHK-R cells, and the electroporated cells were seeded onto DBT cells. The supernatant was 169 harvested 36 hours post-electroporation and plaque assay was performed as described previously 170 (24). RNA was extracted from infected DBT cells at 8 hours post-infection using RNeasy Mini 171 (Qiagen) and cDNA was generated using RT 2 First Strand Kit (Qiagen). PCR was performed 172 using replicase primers (Table 1 ) and purified PCR product was sequenced (amino acids 747-173 848). AM2 and AM3 were plaque purified and AM2 was subjected to deep sequencing. 174 Temperature Shift Experiment. DBT cells in 6-well plates were infected with 0.1 MOI of 175 wild-type MHV or AM2 at 37°C. At 2, 4, or 6 hours post infection, cells were moved to 39.5°C 176 until 14 hours post-infection when supernatant was harvested and virus titer was determined by 177 plaque assay at 37°C as described previously (25) .
178
Expression and purification of wild-type and V787S mutant proteins. The PLP2 sequence 179 was cloned from pCAGGS-MCS-PLP2 (described above) into LIC vector pEV-L8, which is a 180 modified pET-30 plasmid. The expression of wild-type PLP2 and V787S mutant was performed 181 9 using Escherichia coli strain BL21 (DE3). Cultures were grown in LB medium supplemented 182 with kanamycin (50 ug/ml) at 37°C until the optical density at 600nm (A600) reached 0.6. PLP2 183 expression was then induced with 0.1mM isopropyl-β-D-thiogalactopyranoside (IPTG) at 25°C 184 for 6h. Wild-type PLP2 was induced at 25°C for 6 h, while the V787S mutant was induced at 185 18°C overnight. Cells were harvested by centrifugation at 4,690 × g for 20 min at 4°C and stored 186 at -80°C until use. Cell pellets from 1 L culture were then resuspended in 40mL buffer A (25mM 187 Tris pH 7.0, 500mM NaCl, 20mM imidazole, 5mM βME) supplemented with dissolved flakes of 188 lysozyme and DNase, lysed through sonication and centrifuged at 28,880 × g for 30 min (4°C).
189
The supernatant was filtered through a 0.45μm membrane (Millipore) and loaded onto a 5ml Ni
190
HiTrap HP column (GE healthcare) pre-equilibrated with buffer A. Then the column was washed 191 with buffer A supplemented with 5% buffer B (25mM Tris pH 7.0, 500mM NaCl, 500mM 192 imidazole, 5mM βME) until the UV was back to the baseline. The protein was eluted through a 193 gradient of 5%-100% buffer B in 30 column volumes (CV). Fractions were collected and then 194 pooled after enzymatic activity and purity assessment. The n-terminal (His) 8 -tag was then 195 removed by TEV protease (His-tagged) cleavage by incubating PLP2 and TEV-protease together 196 overnight at 4°C while dialyzing into buffer C (25mM Tris pH 7.0, 100mM NaCl, 10mM βME).
197
Then, free His-tag and TEV protease and uncleaved PLP2 were then separated from cleaved 198 PLP2 by running the sample over a Ni 2+ -charged HiTrap column. The flowthrough was 199 collected and then concentrated using Millipore Micron concentrators to a volume of less than 2 200 mL. The concentrated sample was loaded onto a Superdex-75 Hiload 26/60 column (GE 201 Healthcare) pre-equilibrated with buffer D (50mM HEPES pH 7.0, 100mM NaCl, 10mM DTT), 202 and eluted at a flow rate of 2 ml/min. Fractions containing active enzyme at high purity, as 203 judged by SDS-PAGE, were pooled, concentrated and flash-frozen in 2% glycerol using liquid 204 nitrogen for storage at -80°C. out when the enzymes were incubated at 30°C. To analyze the kinetic data, the ratio of the 213 reaction rate at time=t to the rate at time=0 was plotted on a logarithmic scale against incubation 214 time. Kinetic data of the V787S PLP2 incubated at 30°C were fitted to a first-order exponential 215 decay model (Rate t /Rate 0 = e -kt ), from which the inactivation rate constant k inact and half-life t 1/2 216 were determined. The wild-type data were fit to a line since no significant temperature 217 inactivation was observed.
218
Thermal melting temperature (T m ) analysis using circular dichroism (CD). Thermal melting 219 analyses of the wild-type PLP2 and V787S mutant was carried out with a Chirascan circular 220 dichrosim (CD) spectrometer (Applied Photophysics) equipped with a temperature control 221 system (Quantum Northwest Inc.) by monitoring the CD signal at 220nm while increasing the 222 temperature at a step interval of 0.4°C and at a rate 0.5°C/min. Two ml of Protein samples at experiments for both wild-type and V787S mutant MHV PLP2. The melting temperatures (T m ) 226 were calculated as the first derivative peak using the program SigmaPlot.
227
Generation of bone-marrow derived macrophages and virus infection. Femur and tibia from 228 8-week old C57BL/6 female mice were prepared and bone-marrow was isolated, and cultured in 229 IMDM with 10% FCS, 1% pen-strep, 0.1% beta-mercaptoethanol and 5% MCSF obtained from 230 L929-supernatants. Additional medium was added at day 3 post-isolation and cells were seeded 231 at day 6 at a density of 2 * 10 5 cells/well. The following day, cells were infected with wild-type 232 icMHV A59 and AM2 at an MOI of 1. Medium was changed after two hours and supernatant To identify domains and residues within nsp3 that modulate protease activity, we 258 generated a synthetic, codon-optimized parent construct encoding the protease (PLP2, residues 259 699-1087) in-frame with a V5 epitope tag ( Fig. 1A) and introduced a series of mutations into the 260 predicted ubiquitin-like domain 2 ( Fig. 1B) . Protease activity was evaluated using an established 261 trans-cleavage assay (Fig. 1C ). Our goal was to identify a domain that modulated, but did not 262 inactivate protease activity. As a negative control, we generated a PLP2 catalytic mutant 263 (C890A) that was inactive in the trans-cleavage assay. We generated a quadruple mutant (aa 264 785-788 VDVL/SSSS) and specific single mutants: V785S, D786K, and V787S. We found that 265 substitution of specific residues within the ubiquitin-like domain 2 adjacent to PLP2 consistently 266 affected protease activity and reduced the abundance of cleavage product detected in the trans-267 cleavage assay when compared to the activity of PLP2-WT (Fig. 1C) . To determine the degree to 268 which mutants' protease activity declined we used the recently described GloSensor assay (41). 269 We found that, consistent with trans-cleavage assay results, all Ubl-2 mutants had decreased 270 protease activity. However, VDVL/SSSS, V785S, and V787S showed the highest defect in 271 protease activity, while D786K showed intermediate phenotype (Fig. 1D ). In these experiments 272 similar levels of PLP2 wild-type and mutants were expressed in each sample. These results 273 implicated the Ubl-2 domain as a modulator of viral protease activity in MHV. Further, we 274 determined the deubiquitinating (DUB) activity of the Ubl-2 mutants. We found that quadruple 275 mutant and the single mutants V785S, and V787S had reduced DUB activity compared to wild-276 type PLP2. In contrast, D786K mutant had similar DUB activity to wild-type PLP2 (Fig. 1E ).
277
Therefore, we focused on the Ubl-2 V785S and V787S mutants since these Ubl mutants 278 exhibited the most significant defects in the cell-based assays.
279
Ubl-2 mutant virus MHV-AM2 is temperature sensitive 280 To determine if substitutions in the Ubl-2 domain affected virus replication, we used 281 reverse genetics (42) to introduce specific mutations into the viral genome and assessed viral 282 replication. Since the phenotype of the mutations in the PLP2 assay ( Fig. 1) can be different 283 from the phenotype of the mutant in the context of replicating virus we generated viruses 284 encoding a quadruple mutation VDVL/SSSS, designated MHV-AM1, a single mutation V787S, 285 designated MHV-AM2, and another single mutation V785S, designated MHV-AM3 ( Fig. 2A ).
286
The presence of the mutations was confirmed by sequencing within the PLP2 domain. MHV-287 AM1 was highly impaired, generated pinpoint size plaques, and grew to low titer (1x10 3 288 PFU/ml). The low titer and pinpoint plaques generated by AM1 are likely due to the quadruple 289 mutation in PLP2; however, we cannot rule out the possibility that additional mutations outside 290 of PLP2 contribute to this phenotype.
291
In contrast, AM2 and AM3 viruses with single amino acid substitutions within the Ubl-2 292 domain replicated to titers similar to the parent infectious clone. We found that both AM2 and 293 AM3 viruses generated slightly smaller plaques than those generated by wild-type MHV A59.
294
The small plaque phenotype can be associated with temperature sensitivity, so we evaluated 295 relative plaque size of wild-type and AM2 by performing plaque assays at 39.5°C and 40.5°C. 296 We found that AM2 produced small plaques at 39.5°C (about 50% reduction compared to wild-297 type), but was unable to generate plaques at 40.5°C (Fig. 2B ), consistent with a temperature 298 sensitive defect. AM3 also produced slightly smaller than wild-type plaques but bigger than 299 AM2 plaques at 39.5°C (about 20% reduction compared to wild-type) (data not shown). Because 300 the temperature sensitive phenotype was more severe for AM2 and because V787 is conserved in 301 other betacoronaviruses such as SARS-CoV and MERS-CoV ( Fig. 1B) , we focused our studies 302 on AM2. We verified the engineered sequence of AM2 by deep sequencing the viral genomic 303 RNA. The 2-nucleotide substitution (gtc to ccc) of V787 was confirmed, and no additional 304 changes were detected (GenBank # in progress).
305
To determine the replication kinetics of AM2, we infected DBT cells with isogenic wild-306 type MHV-A59 or AM2 virus at MOI of 0.1. The cells were incubated at 37°C, supernatant was 307 harvested and virus titer was determined by plaque assay. We found that at 37°C, AM2 308 replicated with similar kinetics to wild-type virus (Fig. 3A) . In addition, no replication defect 309 was observed in bone marrow derived macrophages, important primary target cells during MHV 310 infection (Fig. 3B ). However, if infected DBT cells were shifted to a higher temperature (39.5°C) 311 there was a progressive reduction in viral titer with increased time at the higher temperature ( Fig.   312 3C). When the cells were incubated at 37°C for 6 hours and then shifted to the higher 313 temperature, the difference between the titers of WT and AM2 was about half a log. In contrast, 314 15 when the infected cells were incubated at 37°C for two hours and then shifted to 39.5°C, the titer 315 of AM2 was two logs lower compared to wild-type virus. Taken together, these data show that 316 AM2 encoding V787S has a temperature sensitive defect in viral replication.
317
Nsp3-V787S substitution impairs PLP2 thermal stability 318 To investigate the temperature sensitive phenotype conferred by the V787S substitution, 319 we expressed the wild-type and V787S mutant of MHV PLP2 in E. coli and then purified the 320 enzymes to homogeneity using a multi-step chromatography procedure (Fig. 4A ). The thermal 321 stability of the wild-type and V787S purified enzymes was then determined at 25°C and at 30°C 322 by measuring the specific activity of the enzymes as a function of incubation time using the 323 peptide-RLRGG-AMC as a substrate. We found that when wild-type and V787S mutant PLP2s 324 were incubated at 25°C, both enzymes were stable over the incubation time course and had 325 similar specific activity (Fig. 4B) . The activities in Fig. 4B have been normalized to 100%. In 326 contrast, when wild-type and V787S mutant PLP2s were incubated at a higher temperature 327 (30°C), the specific activity of V787S PLP2 decreased rapidly over time whereas the wild-type 328 protein maintained full activity (Fig. 4B) . These results indicate that the V787S enzyme is 329 thermally unstable at 30°C with a half-life of 27.7±1.1 min.
330
To determine the relative structural stability of the purified proteins over a wider 331 temperature range, we performed thermal-denaturation experiments using circular dichroism 332 (CD) analysis to determine the melting temperatures (T m ) of each enzyme. Consistent with 333 Figure 4B , the V787S mutant exhibited diminished thermostability (Fig. 4C) . The determined 334 melting temperature was 6.8°C lower for the V787S mutant protein than for the wild-type PLP2, 335 suggesting that the V787S mutant PLP2 is less stable and unfolds at a lower temperature than 336 wild-type PLP2. Taken together, our data indicate that the V787S substitution diminished the 337 16 overall protein thermal stability resulting in decreased enzymatic activity at elevated 338 temperatures.
339

AM2 exhibits reduced pathogenesis and elicits a protective response in mice 340
To determine the effect of the Ubl-2 domain mutation on virus pathogenesis, we infected 341 4-week old male C57B/L6 mice with 600 PFU of wild-type or AM2 virus by intracranial 342 injection. We monitored weight loss over the course of infection and mice were humanely 343 euthanized if they lost greater than 25% of initial body weight. We observed that while 100% of 344 mice infected with wild-type virus succumbed to infection by day 7, all mice infected with AM2 345 survived the infection (Fig. 5A ). We confirmed that the mutation in AM2 was maintained upon 346 mice infection by sequencing within the PLP2 domain of recovered AM2. 347 We detected similar viral titers in the brains of wild-type or AM2-infected mice at day 3 348 or day 5 post infection (Fig. 5B) . In contrast we found levels of viral replicase and IL-6 were 349 reduced in the livers of AM2 infected mice at day 5 post infection compared to wild-type MHV 350 infected mice (Fig. 5C ). There was no difference in CCL2 or IFN-α (data not shown).
351
Furthermore, we analyzed livers for changes in pathology, and observed a reduction in the size 352 of the lesions, hepatocyte necrosis, and inflammation in AM2 infected mice compared to wild-353 type infected (Fig. 5D ). These data indicate that AM2 is attenuated compared to wild-type MHV.
354
To determine if primary infection with AM2 mutant virus protected mice from challenge 355 with wild-type virus, we infected AM2 immunized and age-matched naïve C57BL/6 mice 356 intracranially with 6000 PFU of wild-type virus at 9 weeks post primary infection. We monitored 357 body weight loss over the course of infection and found that naïve mice lost significantly more 358 weight starting at day 2 post-infection (Fig. 5E ). In contrast, AM2 immunized mice did not lose 359 weight and did not exhibit other symptoms of disease upon challenge. 13-week old C57BL/6 are 360 much more resistant to infection than 4-week mice, so as expected, no wild-type or AM2 361 infected mice succumbed to the infection. These results indicate that the immunization with 362 AM2 generated a sufficient immune response to protect the mice from subsequent wild-type 363 challenge. exonuclease, and RNA-dependent RNA polymerase (see Figure 1 ). Previous studies have shown 370 that inactivation of the coronavirus papain-like protease by mutagenesis of the required catalytic 371 cysteine residue or inhibition with a protease inhibitor, blocks viral replication (24, 37, 43) .
372
These approaches demonstrate the requirement for protease activity, but represent "all or 373 nothing" approaches and do not allow for the study of reduced or impaired protease activity.
374
Here, we describe an approach involving mutation of the domain adjacent to the papain-like 375 protease domain, termed the ubiquitin-like domain (Ubl). Structural studies revealed that this 376 domain is highly conserved in coronaviruses, although the function of this domain is unknown. 377 We found that mutation of the Ubl domain destabilizes the adjacent protease domain, leading to 378 loss of enzymatic activity over time (half-life ~30 min at 30°C). When this mutation is 379 introduced into the virus, the mutant virus replicates efficiently in cell culture at 37°C, but is 380 temperature sensitive and unable to replicate at high temperature (40.5°C). Indeed, we found 381 that this virus is highly attenuated in infected mice but does replicate sufficiently to induce a 382 protective immune response against wild-type virus. Overall, our studies revealed a new domain 383 that can be exploited for attenuating the pathogenesis of a coronavirus. 384 Ubl domains have been identified as adjacent to many viral and cellular proteases, with other cellular proteins such as GMP synthetase, which enhances the activity of USP7 (47).
393
Previous studies have shown that the presence of the Ubl domain of SARS-CoV PLpro is 394 necessary for efficient expression and purification of the enzyme (37). To understand the 395 mechanism by which mutations in the Ubl domain of MHV PLP2 affected function, we mapped 396 the mutated residues V785 and V787 into the recently solved crystal structure of MHV PLP2 397 ( Fig. 6) (Chen et al., in preparation) . Interestingly, the overall fold of the protease and Ubl-2 398 domain is conserved between SARS-CoV PLpro and MHV PLP2. Valine 787, which is the 399 focus of this study, is conserved between MHV and highly pathogenic coronaviruses such as 400 SARS-CoV and MERS-CoV (Fig. 1B) . Valine 787 resides within a β-sheet that helps to 401 maintain the structure of the Ubl. The side chains of valine 785 and valine 787 participate in the 402 formation of a hydrophobic core of the Ubl, which stabilizes this domain. By mutating valine 403 787 to serine, we introduced a polar side chain that is energetically unable to pack into the 404 hydrophobic core because of significant desolvation penalties. Therefore, mutation of valine-405 19 787 or valine 785 likely disrupts the structure of the Ubl domain thereby leading to the overall 406 destabilization of PLP2 catalytic domain at elevated temperature. As a consequence, the Ubl 407 mutant enzyme has decreased thermal stability that results in a loss of the specific activity of the 408 enzyme over time in vitro. Furthermore, the destabilization of Ubl-2-PLP2 has an important 409 impact on virus pathogenesis since we found that MHV-AM2 is attenuated in vivo. 410 Interestingly, our studies revealed that the most dramatic reduction in AM2 viral titer in 411 the mice was in the liver, not the brain, which was the site of inoculation. Since MHV-A59 is 412 hepatotropic, it rapidly disseminates to the liver of infected animals (19). The reduction in viral 413 titer in the liver and the decreased size of lesions in the liver (Fig. 5 ) could be due to either 414 defective viral replication or a more rapid immune response to clear the virus from the liver.
415
Similar phenotype of virus attenuated in the liver but not the brain was described for MHV-A59 416 ns2 mutant (48, 49) . In addition, a recent study by Zhang and colleagues showed that an nsp1 417 mutant virus is attenuated in the liver but replicates efficiently in the brain (50). The attenuated 418 phenotype of the nsp1 mutant virus is hypothesized to be due to a more robust immune response 419 to the virus.
420
Recent studies on MERS-CoV showed that PLpro has DUB activity and that this activity 421 is important for antagonism of innate immune response in transfected cells (31, 51) . In addition, 422 the arterivirus equine arteritis virus (EAV) PLP DUB activity has been shown to be involved in Temperature-dependent inactivation of wild-type and PLP2-V787S mutant. The specific activity 690 of wild-type (WT) and the V787S mutant PLP2 enzymes were measured after incubation at 25°C 691 and 30°C for different time periods. The specific activities were then normalized to the activity 692 at 0 min (Rate t /Rate 0 : rate at time t over initial rate). Kinetic data for the V787S mutant 693 incubated at 30°C were fit to a first-order exponential decay model (Rate t /Rate 0 = e -kt ). The 694 calculated inactivation rate constant k inact for the V787S mutant at 30°C is 0.025 ± 0.001 min -1 695 and the half-life (t 1/2 ) is 27.7 ± 1.1 min. C) CD melting curves of WT and PLP2-V787S mutant 696 PLP2. The thermal stability of WT and V787S mutant PLP2 was determined by measuring the 697 CD signal at 220 nm as a function of temperature at a step interval of 0.4°C and at a rate 698 0.5°C/min. Three independent experiments were performed for both WT PLP2 (grey) and 699 V787S mutant (black). 700 Figure 5 . MHV AM2 is attenuated and generated protective immunity in mice. A) C57BL/6 701 mice were infected with 600 pfu WT icMHV or AM2 mutant intracranially and monitored for 702 survival over time (N=7 for each group). B) Virus titers in brains of mice infected with 600 pfu 703 WT icMHV or AM2 were determined at indicated time points p.i. by plaque assay (N=4 to 5). 
